1.1150
-0.0850
(-7.08%)
As of 12:36:28 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 2 |
| Avg. Estimate | -0.32 | -0.48 | -1.29 | -1.67 |
| Low Estimate | -0.32 | -0.48 | -1.29 | -2.59 |
| High Estimate | -0.32 | -0.48 | -1.29 | -0.76 |
| Year Ago EPS | -0.27 | -0.25 | -1.19 | -1.29 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 3 | 3 |
| Avg. Estimate | -- | -- | 3.26M | 2.6M |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 5.79M | 5.79M |
| Year Ago Sales | 1.24M | 1.17M | 6.59M | 3.26M |
| Sales Growth (year/est) | -100.00% | -100.00% | -50.51% | -20.44% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -0.25 | -0.43 | -0.39 | -0.22 |
| EPS Actual | -0.27 | -0.25 | -0.26 | -0.42 |
| Difference | -0.02 | 0.18 | 0.13 | -0.2 |
| Surprise % | -8.00% | 41.86% | 33.33% | -90.91% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.32 | -0.48 | -1.29 | -1.67 |
| 7 Days Ago | 0 | 0 | -1.42 | -1.52 |
| 30 Days Ago | 0 | 0 | -2.19 | -2.59 |
| 60 Days Ago | 0 | 0 | -2.19 | -2.59 |
| 90 Days Ago | 0 | 0 | -2.19 | -2.59 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | 1 |
| Up Last 30 Days | -- | -- | -- | 1 |
| Down Last 7 Days | -- | -- | 1 | -- |
| Down Last 30 Days | -- | -- | 1 | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| MRKR | -18.52% | -92.00% | -8.40% | -29.84% |
| S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Upgrades & Downgrades
| Reiterates | WBB Securities: Strong Buy to Strong Buy | 4/1/2025 |
| Initiated | Canaccord Genuity: Buy | 3/5/2025 |
| Initiated | Ladenburg Thalmann: Buy | 4/30/2024 |
Related Tickers
AFMD Affimed N.V.
0.6500
-8.71%
GANX Gain Therapeutics, Inc.
1.8000
-4.76%
ARDS Aridis Pharmaceuticals, Inc.
0.0001
0.00%
IGMS IGM Biosciences, Inc.
1.1800
-4.07%
COYA Coya Therapeutics, Inc.
6.30
-3.67%
OKYO OKYO Pharma Limited
1.2300
-1.60%
RLYB Rallybio Corporation
0.5578
-3.83%
IMNN Imunon, Inc.
1.0100
-3.81%
ANIX Anixa Biosciences, Inc.
2.6600
-3.62%
IKNA Ikena Oncology, Inc.
1.2299
-1.61%